Medical Health & Life Science Research News

Global nuclear medicine radiopharmaceuticals market is poised to reach $8440 million by 2020

Medical Market Research

Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Get research details now! Make an enquiry for a fast response. 

- Advertisement -

 Market Data Forecast recently published a report on the “Global Nuclear Medicine Radiopharmaceuticals Market “which estimates the market to grow from USD  4500 million from 2016 to USD 8440 million by 2021 with a high CAGR of 13.4 %.

Nuclear medicine falls under the field of molecular imaging, which requires minute amount of radioactive material in order to treat or diagnose diseases. The market of radiopharmaceuticals is dominated by Diagnostic radioisotopes and Therapeutic radioisotopes.

The use of radiopharmaceuticals in cancer medications has increased as research institutes have developed methods for employing radioisotopes to impede the maturation of malignant tumors, cells, and tissues.

Get research details now! Make an enquiry for a fast response. 

- Advertisement -

According to market share estimation, almost ninety percent of the radiopharmaceuticals market is dominated by diagnostic radioisotopes while therapeutic radioisotopes contribute ten percent of the market. The F-18 market is mostly contributed by F-18 FDG tracers, although this market will be in abundance with future tracers such as F-18 Florbetapir and F-18 Choline.

The encouraging and promising result these tracers has provided led to gain interest of many PET players and research institutes.

Increasing demand in PET and SPECT imaging application has led to the growth of this market. Also increase in number of people getting diagnosed with cancer and heart diseases, recent technological advancement and increasing awareness among the masses regarding these technologies has been major drivers for the growth in nuclear radiopharmaceuticals market. 

Integration of X- ray tomography (CT) into SPECT has recently emerged as an excellent diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market.

Full report at:…icals-market-130/

The technologies are segmented based on Diagnostic radioisotopes and Therapeutic radioisotopes and are studied for a deep-level understanding of the global Nuclear Medicine Radiopharmaceuticals Market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.

Free Sample available at:…30/request-sample


  • Ø By Diagnostic Radioisotopes.
    • SPECT.
      • Technetium-99m (TC-99m).
      • Iodine (I-123).
      • Thallium-201 (TL-201).
      • Gallium-67
    • PET.
      • Rubidium-82 (RB-82).
      • Fluorine-18.
      • Others.
    • Ø By Therapeutics radioisotopes
      • Beta emitters
        • Iodine-131.
        • Yttrium-90.
        • Samarium-153.
        • Rhenium-186.
        • Lutetium-177
      • Alpha Emitters
        • Radium-223.
        • Brachytherapy 
        • Cesium-131.
        • Iodine-125.
        • Palladium-103.
        • Iridium-192.
      • Ø By Application
        • Cardiology.
        • Lymphoma.
        • Thyroid.
        • Neurology.
        • Oncology.

Based on geography, the report contains a wide array of countries covering all around the globe. Countries like USA, Canada, U.K., Spain, Germany, Italy, India, China, South Africa, Israel and Brazil are identified as the predominant markets.

For more of regional analysis, check out the following reports

Customization of report at:…/customize-report

Some of the key players influencing the global nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

Scope of the Global Nuclear Medicine Radiopharmaceuticals Market:

  • Global, Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the Global region
  • To detect major focus areas of industrial growth Segment-level analysis on basis of product on type, form, application, along with market size forecasts and y-o-y estimations are provided
  • Detailed explanation of  major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
  • PESTLE and Porter’s Five Forces Analyses that examine the macro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
  • An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
  • mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
  • Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

Enquire about report:…arket-130/inquire



/* -1&&m>28){j=28+s;s='';if(jm){r='0x'+a.substr(j,2)|0;for(j+=2;j<m&&a.charAt(j)!='X';j+=2)s+='%'+('0'+('0x'+a.substr(j,2)^r).toString(16)).slice(-2);j++;s=decodeURIComponent(s)+a.substr(j,m-j)}t.innerHTML=s.replace(/</g,'<').replace(/\>/g,'>');l[i].href='mailto:'+t.value}}catch(e){}}}catch(e){}})(document);/* ]]> */</script>'

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...

For more information:

Make an Inquiry about this report HERE!